Madrigal Pharmaceuticals, Inc.
Records under this name other than the patents Madrigal Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Back to Madrigal Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,266,861 | Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,968,612 | Method of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,376,517 | Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,894,050 | Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,564,926 | Methods of Synthesizing Thyroid Hormone Analogs and Polymorphs Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,117,944 | Targeted Therapeutics Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 11,377,447 | Targeted Therapeutics Lapsed on the fee record Ended Jul 5, 2026 · High confidence | Lapsed on the fee record | Ended Jul 5, 2026 | High confidence |
| US 8,263,764 | IL-12 Modulatory Compounds Term ended Term ended May 12, 2026 · High confidence | Term ended | Term ended May 12, 2026 | High confidence |
| US 9,956,293 | Targeted Therapeutics Lapsed on the fee record Ended May 1, 2026 · Medium confidence | Lapsed on the fee record | Ended May 1, 2026 | Medium confidence |
| US 8,236,795 | IL-12 Modulatory Compounds Term ended Ended no later than Nov 10, 2025 · Medium confidence | Term ended | Ended no later than Nov 10, 2025 | Medium confidence |